ArticleCureus2025
Bacillus Calmette Guérin Osteomyelitis of the Proximal Tibia Extending to the Physis and Epiphysis in an Immunocompetent Toddler: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacillus Calmette-Guérin (BCG) osteomyelitis is a very rare but serious complication of BCG immunization. Although most affected patients experience a good outcome, late orthopedic complications, such as discrepancy in leg length, are a concern. The impact of the extent of surgical intervention on minimizing orthopedic complications remains unclear, especially in patients with BCG osteomyelitis involving the physis. Here, we report the case of a 22-month-old immunocompetent boy who developed BCG osteomyelitis in the proximal metaphysis of the right tibia, which extended to the physis and epiphysis and was accompanied by a large subcutaneous abscess. In the current case, minimal curettage with anti-tuberculosis drugs, which can prevent damage to the physis and epiphysis, was not beneficial. Hence, complete curettage of the lesions was required. No disruption in bone growth was observed at the last follow-up evaluation performed 32 months after the first visit. Based on our experience, timely and sufficient curettage is essential to control the disease and prevent orthopedic complications in patients with BCG osteomyelitis involving the physis and epiphysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.